Upgrade to SI Premium - Free Trial

Engene (ENGN)

1.87 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (12/23/26)

Latest Headlines

Engene Holdings (ENGN) Reiterated at Market Perform by Citizens September 9, 2026 4:17 AM - StreetInsider Form SCHEDULE 13G/A enGene Therapeutics Inc. Filed by: PERCEPTIVE ADVISORS LLC August 14, 2026 5:22 PM - SEC Filing Form SCHEDULE 13G/A enGene Therapeutics Inc. Filed by: Venrock Healthcare Capital Partners III, L.P. August 14, 2026 4:51 PM - SEC Filing Form SCHEDULE 13G/A enGene Therapeutics Inc. Filed by: Deep Track Capital, LP August 14, 2026 8:25 AM - SEC Filing Form SCHEDULE 13G/A enGene Therapeutics Inc. Filed by: Invus Global Management, LLC August 13, 2026 11:41 AM - SEC Filing Form SCHEDULE 13G/A enGene Therapeutics Inc. Filed by: Blue Owl Capital Holdings LP August 12, 2026 4:32 PM - SEC Filing Form 8-K enGene Therapeutics Inc. For: Aug 11 August 11, 2026 4:04 PM - SEC Filing enGene to Host Virtual KOL Event to Discuss Emerging Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insights, on August 11, 2026 August 4, 2026 8:00 AM - BizWire Form 3 enGene Therapeutics Inc. For: Jul 16 Filed by: Chinoporos Constantine July 22, 2026 4:06 PM - SEC Filing Form 3 enGene Therapeutics Inc. For: Jul 16 Filed by: Richton Kathleen P. July 22, 2026 4:06 PM - SEC Filing Form SCHEDULE 13G enGene Therapeutics Inc. Filed by: ACORN BIOVENTURES, L.P. July 22, 2026 9:14 AM - SEC Filing Form 8-K enGene Therapeutics Inc. For: Jul 17 July 17, 2026 4:06 PM - SEC Filing Form 8-K enGene Therapeutics Inc. For: Jul 15 July 16, 2026 8:07 AM - SEC Filing enGene names new board chairman ahead of planned BLA filing July 16, 2026 8:01 AM - StreetInsider enGene Focuses Board to Support Planned Upcoming Regulatory and Commercial Milestones July 16, 2026 8:00 AM - BizWire Rectify Pharmaceuticals Announces Appointment of Constantine Chinoporos as Executive Chairman July 15, 2026 9:00 AM - Globe NewsWire Form 8-K/A enGene Therapeutics Inc. For: Jun 16 June 18, 2026 4:06 PM - SEC Filing Morgan Stanley Downgrades Engene Holdings Inc. (ENGN) to Underweight June 18, 2026 2:37 AM - StreetInsider Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: Astley-Sparke Philip June 17, 2026 5:44 PM - SEC Filing Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: BRUNK GERALD A June 17, 2026 5:43 PM - SEC Filing Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: Glickman Richard M June 17, 2026 5:42 PM - SEC Filing Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: Grossman William June 17, 2026 5:41 PM - SEC Filing Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: HASTINGS PAUL J June 17, 2026 5:40 PM - SEC Filing Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: Heffernan Michael Thomas June 17, 2026 5:38 PM - SEC Filing Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: Zoth Lota S. June 17, 2026 5:38 PM - SEC Filing Form 4 enGene Therapeutics Inc. For: Jun 16 Filed by: Joustra Wouter June 17, 2026 5:37 PM - SEC Filing Full Article List